Please login to the form below

Not currently logged in
Email:
Password:

Accelerated Access Review

This page shows the latest Accelerated Access Review news and features for those working in and with pharma, biotech and healthcare.

Ex-GSK head Witty to head group overseeing UK fast-track scheme

Ex-GSK head Witty to head group overseeing UK fast-track scheme

be selected for the Government’s new Accelerated Access Pathway (AAP), due to come into effect next April. ... Last October, the independent Accelerated Access Review (AAR) led by Sir High Taylor set out a series of recommendations for streamlining the

Latest news

  • NICE: We're the institute of 'yes' NICE: We're the institute of 'yes'

    The NHS is interested in managing access, not in blocking it," he said adding that NICE and pharma were "in the same business". ... The Strategy also made a series of recommendations that would overlap with and supplement the Accelerated Access Review,

  • Mixed news for pharma on UK's Accelerated Access Review Mixed news for pharma on UK's Accelerated Access Review

    The scheme is the first stage in the independent Accelerated Access Review (AAR) - designed to accelerate patient access to new medicines and devices in the UK - that was published last October. ... It set out a series of recommendations for streamlining

  • NICE to bring HTA processes to mobile health apps NICE to bring HTA processes to mobile health apps

    Its evaluations will build on the Paperless 2020 simplified app assessment process - as recommended in the recent Accelerated Access Review - to create a “digital infrastructure [that] should enable the system to ... The app is currently available on

  • UK to cut wait to innovative treatments by four years UK to cut wait to innovative treatments by four years

    Proposals in the Accelerated Access Review aim to speed up access to innovation. ... Published earlier this week, the 'Accelerated Access Review' sets out a series of recommendations for streamlining the access process for new drugs, medical devices,

  • UK pharma's contribution to NHS hits £1bn mark UK pharma's contribution to NHS hits £1bn mark

    ABPI says local access to new treatments still not universal despite drug rebates. ... We hope that the government's independent Accelerated Access Review … will provide an opportunity to address some of these issues.".

More from news
Approximately 1 fully matching, plus 7 partially matching documents found.

Latest Intelligence

  • Uncertainty, austerity and Brexit Uncertainty, austerity and Brexit

    Alongside this, rumours that NHS England was planning to include biosimilars on the Accelerated Access Pathway, the flagship policy intervention designed to speed up the use of innovative products, would amount ... Sciences Industrial Strategy and the

  • Working with our healthcare system more closely is vital Working with our healthcare system more closely is vital

    Take a recent local NHS partnership aimed at addressing specific access and capacity issues in Southampton. ... Specifically, this should include building on the recommendations put forward in the Life Science Industrial Strategy and the Accelerated

  • Macron, Merkel and May: implications of the 2017 elections for the life science industry Macron, Merkel and May: implications of the 2017 elections for the life science industry

    The ABPI has pursued legal action, arguing that this contravenes the NHS Constitution, which legally entitles patients access to NICE-approved treatments. ... Furthermore, the 2017 Conservative Party election manifesto promised to ‘implement the

  • Lighting the way Lighting the way

    How the UK’s Accelerated Access Review aims to guide medical innovations to their destination. ... She noted that engaging with the government on the new Life Sciences Strategy (see p7) and the Accelerated Access Review were among NICE's top priorities

  • Market access in Europe: balancing access and affordability Market access in Europe: balancing access and affordability

    In October 2016, the Accelerated Access Review (AAR) published its recommendations to the UK government. ... Furthermore, not all of these technologies would necessarily complete the Accelerated Access Pathway.

More from intelligence
Approximately 1 fully matching, plus 5 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Conversis

Conversis is a translation company specialising in translation and localisation for the Life Science and Pharmaceutical industry, with particular focus...

Latest intelligence

Combined immunotherapies – potential and pitfalls
‘Combining therapeutic compounds is the first logical step towards better results, namely higher rates of patients responding to treatment, with deeper and more sustained responses’...
Report: Achieving launch excellence in the challenging healthcare markets of today
Our in-depth report is based on original data and expert interviews, which coupled with our own experience, ensures we give you the best recommendations for achieving launch success in challenging...
What is blockchain and why should i care - Richard Springham
Four Health - Emerging Technologies The power of blockchain lies in the fact it can prove that a unique event occurred at a certain time with out the need to...

Infographics